While these findings collectively suggest a positive trend in the use of Cytosorb® in managing apixaban-associated scenarios, it is essential to acknowledge certain limitations within the existing literature, with the majority of studies being case reports.
← all excerpts
Effective Apixaban removal using hemoadsorption during emergent open-heart surgery: a case report and narrative literature review.
1
—
—